Lurking in groundwater across America, trichloroethylene has been quietly building a case against itself for decades. This industrial chemical, used since the 1920s for dry cleaning and degreasing, now faces mounting evidence linking it to Parkinson’s disease. One-third of U.S. groundwater is contaminated with TCE. That’s not a typo.
Multiple large-scale studies paint a troubling picture. Veterans at Camp Lejeune showed a 70% higher Parkinson’s risk compared to those at clean bases. A nationwide analysis of over 1.3 million people found positive associations between ambient TCE exposure and Parkinson’s disease. The District of Columbia residents in high-exposure areas face a relative risk of 1.46 compared to the national average.
The numbers don’t lie: 70% higher Parkinson’s risk for Camp Lejeune veterans, 1.46 relative risk for high-exposure DC residents.
TCE doesn’t just sit politely in the environment. It crosses the blood-brain barrier with ease, triggering dopaminergic neurodegeneration in animal studies. The chemical causes mitochondrial dysfunction and oxidative stress—both key players in Parkinson’s development. Even worse, chronic exposure may trigger α-synuclein aggregation, a hallmark of the disease. Public health surveillance data continues to strengthen these concerning connections.
The dose-response relationship tells its own story. Two years of heavy TCE exposure translates to roughly 70% increased Parkinson’s risk. Urban populations show stronger associations than rural ones, particularly in Rust Belt regions and areas near industrial sites. Millions face potential exposure through contaminated air, soil, and groundwater.
Geographic patterns reveal uncomfortable truths. High TCE emissions correlate with elevated Parkinson’s rates across multiple regions. Silicon Valley boasts at least 15 Superfund sites contaminated with TCE. West Virginia and the New Jersey-Pennsylvania border show elevated odds ratios in local clusters. The pioneering study by Barrow Neurological Institute represents one of the first to identify a national association between ambient TCE and Parkinson’s disease.
Here’s the kicker: while the U.S. banned TCE as an inhaled anesthetic in the 1970s, industrial use continues today. The EU took a harder stance, banning commercial and consumer applications entirely. Meanwhile, Americans continue breathing, drinking, and living with this persistent pollutant.
The chemical’s longevity in the environment creates decades-long exposure windows. Industrial workers, military personnel, and residents near contaminated sites bear the highest burden. TCE’s ability to contaminate multiple environmental media means escape routes remain limited for affected communities. Unlike the routine testing for radon, few homes are checked for TCE vapor despite its potential for indoor air contamination.
